
AI: The Last Refuge of the Failed Cannabis Company
Late last month, NASDAQ-listed cannabis operator Flora Growth, which once operated one of Colombia’s largest outdoor cultivation facilities, became the

Late last month, NASDAQ-listed cannabis operator Flora Growth, which once operated one of Colombia’s largest outdoor cultivation facilities, became the

After two years of speculation, rumours, stock swings, broken promises, and political theatre, President Donald Trump officially signed an executive

Cannabis Rescheduling fervour has once again reached dramatic levels following media reports that President Donald Trump is considering pushing through

Cannabis stocks enjoyed another spike last week following reports that the Centers for Medicare & Medicaid Services is preparing to

The story of the cannabis sector’s financial health is increasingly split between those providing the capital and those who desperately

From the euphoric highs of 2018’s ‘green rush’ to the sharp corrections and structural stasis that have followed, cannabis equities

The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our

Tilray Tilray has enjoyed a series of significant bumps in stock price over the last couple of weeks, driven largely

Cannabis Stocks Surge on Trump Video Global cannabis stocks have enjoyed a considerable, but likely temporary, run this week, after

Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from

Tilray [stock_market_widget type=”chart” template=”line” assets=”TLRY” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The international cannabis giant

Ananda Pharma [stock_market_widget type=”chart” template=”line” assets=”ANANF” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Just days after

UK-based cannabinoid pharmaceutical company Ananda Pharma has received ethics approval for a Phase 1 clinical study for its lead compound in Australia.

Akanda [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Akanda Corp has become

A proposal for federal legalization of cannabis is now expected to be submitted to the White House by the end of the week, driving a bump in US cannabis stocks.

Cannabis stocks plummeted this week after a judge ordered the Drug Enforcement Agency (DEA) to respond to damning new allegations

Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent Biopharma (previously

Hellenic Dynamics Hellenic Dynamics has announced a further delay in the receipt of a long-term €1m loan, which has already